Thursday, September 09, 2010
   
TEXT_SIZE

Press Releases

Title Filter 

Display # 
# Article Title
1 August 11, 2010 - Mymetics Corporation announces new Chief Financial Officer
2 June 28, 2010 - Mymetics’ Respiratory Syncytial Virus (RSV) vaccine protects from viral challenge in pre-clinical study
3 June 16, 2010 - Mymetics’ Phase Ib Malaria Vaccine: Safe, Well Tolerated and Long-Lasting Antibody Response in Children in Tanzania
4 January 19, 2010 - Mymetics Corporation: the First Human Vaccinations of Mymetics’ Preventative HIV Vaccine Candidate are well tolerated
5 October 20, 2009 - Mymetics Corporation presents ground breaking results with preventative HIV vaccine at the World AIDS Vaccine Congress in Paris 19 – 22 October
6 September 8, 2009 -- Mymetics Corporation announces the appointment of Dr. Stanley Plotkin as Chairman of the Scientific Advisory Board and election of new members
7 June 22, 2009 -- Mymetics Corporation's Board of Directors announces the Appointment of Jacques-François Martin as President and CEO
8 March 9, 2009 -- Mymetics Corporation acquires Virosome Biologicals B.V.
9 February 9, 2009 -- Mymetics Corporation announces success of its preventive vaccine against HIV/AIDS and commencement of European phase 1 Human Clinical trials
10 December 09, 2008 -- Mymetics Corporation Retains Lazard Bank to further the Company's merger, acquisition and expansion activities

Page 1 of 2